{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:21:01Z","timestamp":1791685261139,"version":"4.3.4"},"reference-count":193,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2014.00071","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T13:16:24Z","timestamp":1398258984000},"source":"Crossref","is-referenced-by-count":49,"title":["Possible modification of Alzheimer\u00e2\u20ac\u2122s disease by statins in midlife: interactions with genetic and non-genetic risk factors"],"prefix":"10.3389","volume":"6","author":[{"given":"Mitsuru","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehisa","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kurinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarnath","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm0204-117","article-title":"Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.","volume":"10","author":"Akiyama","year":"2004","journal-title":"Nat. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer\u00e2\u20ac\u2122s disease facts and figures.","volume":"9","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","article-title":"Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.","volume":"8","author":"Amarenco","year":"2009","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","article-title":"Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis.","volume":"16","author":"Anstey","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u00e2\u20ac\u2122s disease.","volume":"1)","author":"Arriagada","year":"1992","journal-title":"Neurology 42(Pt"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","article-title":"Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.","volume":"2)","author":"Arvanitakis","year":"2008","journal-title":"Neurology 70(Pt"},{"key":"B7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/JMN:23:3:157","article-title":"APOE genotype effects on Alzheimer\u00e2\u20ac\u2122s disease onset and epidemiology.","volume":"23","author":"Ashford","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u00e2\u20ac\u2122s disease.","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-006-0136-y","article-title":"Circle of Willis atherosclerosis: association with Alzheimer\u00e2\u20ac\u2122s disease, neuritic plaques and neurofibrillary tangles.","volume":"113","author":"Beach","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood\u00e2\u20ac\u201cbrain barrier disorder in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JAD-2009-1041","article-title":"Oxidative stress in vascular dementia and Alzheimer\u00e2\u20ac\u2122s disease: a common pathology.","volume":"17","author":"Bennett","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.","volume":"21","author":"Bettermann","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1467-789X.2008.00473.x","article-title":"Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.","volume":"9","author":"Beydoun","year":"2008","journal-title":"Obes. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/NEN.0b013e31819ac3cb","article-title":"Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy.","volume":"68","author":"Boimel","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u00e2\u20ac\u2122s disease: pathways, pathogenesis and therapy.","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1474-4422(08)70271-0","article-title":"Alzheimer\u00e2\u20ac\u2122s disease: on the verges of treatment and prevention.","volume":"8","author":"Burns","year":"2009","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1385\/NMM:8:3:319","article-title":"Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice.","volume":"8","author":"Burns","year":"2006","journal-title":"Neuromol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phrs.2011.04.007","article-title":"Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.","volume":"64","author":"Butterfield","year":"2011","journal-title":"Pharmacol. Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2008-13209","article-title":"Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer\u00e2\u20ac\u2122s disease.","volume":"13","author":"Carlsson","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.imbio.2011.07.017","article-title":"Complement receptor 1 (CR1) and Alzheimer\u00e2\u20ac\u2122s disease.","volume":"217","author":"Crehan","year":"2012","journal-title":"Immunobiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/archinte.1997.00440330039004","article-title":"Reductase inhibitor monotherapy and stroke prevention.","volume":"157","author":"Crouse","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1172\/JCI119887","article-title":"Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.","volume":"101","author":"Cullen","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u00e2\u20ac\u2122s disease.","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1185\/030079906X167516","article-title":"Impact of gender on statin efficacy.","volume":"23","author":"Dale","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4155\/fmc.12.51","article-title":"Is RAGE still a therapeutic target for Alzheimer\u00e2\u20ac\u2122s disease?","volume":"4","author":"Deane","year":"2012","journal-title":"Future Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","article-title":"Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.","volume":"77","author":"Debette","year":"2011","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jacc.2009.07.062","article-title":"Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials.","volume":"55","author":"De Caterina","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B31","first-page":"1","article-title":"Neuropathology of non-Alzheimer degenerative disorders.","volume":"3","author":"Dickson","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal.","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study.","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/01.WNL.0000160114.42643.31","article-title":"APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.","volume":"64","author":"Dufouil","year":"2005","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.nbd.2009.05.005","article-title":"Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.","volume":"35","author":"Eckert","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosissup.2004.08.026","article-title":"The discovery and development of HMG-CoA reductase inhibitors. 1992.","volume":"5","author":"Endo","year":"2004","journal-title":"Atheroscler. Suppl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1008-1050","article-title":"A gift from nature: the birth of the statins.","volume":"14","author":"Endo","year":"2008","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1592\/phco.29.7.800","article-title":"Statin-associated adverse cognitive effects: survey results from 171 patients.","volume":"29","author":"Evans","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"240","key":"B39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.240","article-title":"Serum cholesterol, APOE genotype, and the risk of Alzheimer\u00e2\u20ac\u2122s disease: a population-based study of African Americans.","volume":"54","author":"Evans","year":"2000","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1471-4159.2001.00063.x","article-title":"Cholesterol-dependent modulation of tau phosphorylation in cultured neurons.","volume":"76","author":"Fan","year":"2001","journal-title":"J. Neurochem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u00e2\u20ac\u2122s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","article-title":"Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.","volume":"106","author":"Filippini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor.","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/WAD.0b013e3181611024","article-title":"A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study.","volume":"22","author":"Gomez-Isla","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u00e2\u20ac\u2122s disease risk gene CD33 inhibits microglial uptake of amyloid beta.","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"B47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1471-4159.2009.06126.x","article-title":"Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface.","volume":"110","author":"Guardia-Laguarta","year":"2009","journal-title":"J. Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.","volume":"80","author":"Haag","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"117","author":"Heneka","year":"2010","journal-title":"J. Neural Transm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00221-005-2243-8","article-title":"Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"164","author":"Hoglund","year":"2005a","journal-title":"Exp. Brain Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000084550","article-title":"The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer\u00e2\u20ac\u2122s disease.","volume":"19","author":"Hoglund","year":"2005b","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.61.3.333","article-title":"Plasma levels of beta-amyloid (1\u00e2\u20ac\u201c40), beta-amyloid (1\u00e2\u20ac\u201c42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.","volume":"61","author":"Hoglund","year":"2004","journal-title":"Arch. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u00ce\u00b242 immunisation in Alzheimer\u00e2\u20ac\u2122s disease: follow-up of a randomised, placebo-controlled phase I trial.","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1515\/dmdi.2011.107","article-title":"Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.","volume":"26","author":"Hubacek","year":"2011","journal-title":"Drug Metab. Drug Interact."},{"key":"B56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"19","key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2010.00019","article-title":"Are NSAIDs useful to treat Alzheimer\u00e2\u20ac\u2122s disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0304-3940(03)00895-4","article-title":"Pravastatin at 10 mg\/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans.","volume":"350","author":"Ishii","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u00e2\u20ac\u2122s disease: an updated hypothetical model of dynamic biomarkers.","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u00e2\u20ac\u2122s pathological cascade.","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer\u00e2\u20ac\u2122s disease.","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u00e2\u20ac\u2122s disease patients.","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia.","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).","volume":"81","author":"Jones","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/WNL.51.3.728","article-title":"The incidence of dementia.","volume":"51","author":"Jorm","year":"1998","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer\u00e2\u20ac\u2122s amyloid-beta.","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","article-title":"Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer\u00e2\u20ac\u2122s disease.","volume":"33","author":"Kim","year":"2013","journal-title":"J. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1592\/phco.23.15.1663.31953","article-title":"Cognitive impairment associated with atorvastatin and simvastatin.","volume":"23","author":"King","year":"2003","journal-title":"Pharmacotherapy"},{"key":"B70","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u00e2\u20ac\u2122s disease.","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E \u00e2\u02c6\u01604 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B73","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/138161208783497769","article-title":"Apolipoprotein E knockout models.","volume":"14","author":"Kolovou","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.arr.2006.11.001","article-title":"Apolipoprotein E polymorphism, age and coronary heart disease.","volume":"6","author":"Kolovou","year":"2007","journal-title":"Ageing Res. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbalip.2010.03.001","article-title":"Alterations of cholesterol precursor levels in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"1801","author":"K\u00c3\u00b6lsch","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B76","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neulet.2004.07.031","article-title":"Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.","volume":"368","author":"K\u00c3\u00b6lsch","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2012.06.011","article-title":"Statins have therapeutic potential for the treatment of Alzheimer\u00e2\u20ac\u2122s disease, likely via protection of the neurovascular unit in the AD brain.","volume":"322","author":"Kurata","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3892\/ijmm.21.5.531","article-title":"Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.","volume":"21","author":"Kurinami","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/157016110790226642","article-title":"Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.","volume":"8","author":"Lanati","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"45512","DOI":"10.1074\/jbc.M407461200","article-title":"Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.","volume":"279","author":"Landrier","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.109.147389","article-title":"Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program\/Honolulu Asia Aging Study.","volume":"55","author":"Launer","year":"2010","journal-title":"Hypertension"},{"key":"B82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study.","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2005.11.046","article-title":"Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?","volume":"397","author":"Leoni","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","article-title":"Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.","volume":"63","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1532-5415.2010.02906.x","article-title":"Age-varying association between statin use and incident Alzheimer\u00e2\u20ac\u2122s disease.","volume":"58","author":"Li","year":"2010a","journal-title":"J. Am. Geriatr. Soc."},{"issue":"b5465","key":"B87","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.","volume":"340","author":"Li","year":"2010b","journal-title":"BMJ"},{"key":"B88","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.21053","article-title":"Simvastatin enhances learning and memory independent of amyloid load in mice.","volume":"60","author":"Li","year":"2006","journal-title":"Ann. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins.","volume":"45","author":"Liao","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B90","first-page":"1864","article-title":"Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin.","volume":"123","author":"Lu","year":"2010","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"e4144","key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004144","article-title":"Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.","volume":"4","author":"Lu","year":"2009","journal-title":"PLoS ONE"},{"key":"B92","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1194\/jlr.M600259-JLR200","article-title":"Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor.","volume":"48","author":"Lucic","year":"2007","journal-title":"J. Lipid Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJM198108273050902","article-title":"Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.","volume":"305","author":"Mabuchi","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on Alzheimer\u00e2\u20ac\u2122s disease.","volume":"41","author":"Maccioni","year":"2010","journal-title":"Arch. Med. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1093\/brain\/awl251","article-title":"Alzheimer\u00e2\u20ac\u2122s centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.","volume":"11)","author":"Masters","year":"2006","journal-title":"Brain 129(Pt"},{"issue":"9","key":"B98","doi-asserted-by":"publisher","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0404.2006.00681.x","article-title":"Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function.","volume":"185","author":"Michikawa","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"B100","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00002093-199809000-00012","article-title":"Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.","volume":"12","author":"Mulder","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B102","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JAD-2010-100639","article-title":"Changes in cognition and amyloid-beta processing with long term cholesterol reduction using atorvastatin in aged dogs.","volume":"22","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/07853890310001294","article-title":"A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms.","volume":"35","author":"Nakagami","year":"2003","journal-title":"Ann. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc09-2038","article-title":"Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study.","volume":"33","author":"Nooyens","year":"2010","journal-title":"Diabetes Care"},{"key":"B105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u00e2\u20ac\u2122s disease.","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"B106","article-title":"\u00e2\u20ac\u0153Pitavastatin for the delay or prevention of diabetes development in individuals with impaired glucose tolerance,\u00e2\u20ac\u009d in","author":"Odawara","year":"2013","journal-title":"73rd Scientific Sessions"},{"key":"B107","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2006.00692.x","article-title":"Cholesterol, statins and tau.","volume":"185","author":"Ohm","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"832379","key":"B108","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/832379","article-title":"Genetics of late-onset Alzheimer\u00e2\u20ac\u2122s disease: update from the alzgene database and analysis of shared pathways.","volume":"2011","author":"Olgiati","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2007.03.004","article-title":"Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.","volume":"197","author":"Ooi","year":"2008","journal-title":"Atherosclerosis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1592\/phco.21.7.767.34577","article-title":"Simvastatin-associated memory loss.","volume":"21","author":"Orsi","year":"2001","journal-title":"Pharmacotherapy"},{"key":"B111","doi-asserted-by":"publisher","first-page":"26832","DOI":"10.1074\/jbc.M702640200","article-title":"Statins reduce amyloid-beta production through inhibition of protein isoprenylation.","volume":"282","author":"Ostrowski","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.amjopharm.2012.08.002","article-title":"The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer\u00e2\u20ac\u2122s dementia: a prospective withdrawal and rechallenge pilot study.","volume":"10","author":"Padala","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-3956(01)00050-4","article-title":"24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.","volume":"36","author":"Papassotiropoulos","year":"2002","journal-title":"J. Psychiatr. Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.","volume":"61","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0197-4580(02)00155-0","article-title":"Lovastatin enhances A[beta] production and senile plaque deposition in female Tg2576 mice.","volume":"24","author":"Park","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B116","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20060655","article-title":"Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.","volume":"399","author":"Parsons","year":"2006","journal-title":"Biochem. J."},{"key":"B117","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","article-title":"Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway.","volume":"98","author":"Paumelle","year":"2006","journal-title":"Circ. Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/01.RES.0000269334.42814.d2","article-title":"Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.","volume":"100","author":"Paumelle","year":"2007","journal-title":"Circ. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment.","volume":"352","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1196\/annals.1427.010","article-title":"Evidence of oxidative stress in Alzheimer\u00e2\u20ac\u2122s disease brain and antioxidant therapy: lights and shadows.","volume":"1147","author":"Pratico","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/35006165","article-title":"Apolipoprotein E and cognitive performance.","volume":"404","author":"Raber","year":"2000","journal-title":"Nature"},{"key":"B122","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1042\/bj3220893","article-title":"Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content.","volume":"3)","author":"Racchi","year":"1997","journal-title":"Biochem. J. 322(Pt"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: the cardiovascular health study.","volume":"62","author":"Rea","year":"2005","journal-title":"Arch. Neurol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u00e2\u20ac\u2122s amyloid pathology in a transgenic mouse model.","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-\u00ce\u00b2 burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u00e2\u20ac\u2122s disease.","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch. Neurol."},{"key":"B127","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2006-10408","article-title":"Effect of statins on Alzheimer\u00e2\u20ac\u2122s disease biomarkers in cerebrospinal fluid.","volume":"10","author":"Riekse","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.","volume":"59","author":"Rockwood","year":"2002","journal-title":"Arch. Neurol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.neuint.2007.02.001","article-title":"Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells.","volume":"50","author":"Roensch","year":"2007","journal-title":"Neurochem. Int."},{"key":"B130","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1124\/jpet.302.1.232","article-title":"Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.","volume":"302","author":"Roglans","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1345\/aph.1Q620","article-title":"Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.","volume":"46","author":"Rojas-Fernandez","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1212\/WNL.53.3.517","article-title":"APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.","volume":"53","author":"Romas","year":"1999","journal-title":"Neurology"},{"key":"B133","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2004-6602","article-title":"Is there a characteristic lipid profile in Alzheimer\u00e2\u20ac\u2122s disease?","volume":"6","author":"Sabbagh","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors.","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer\u00e2\u20ac\u2122s disease.","volume":"24","author":"Sagare","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u00e2\u20ac\u2122s disease. The Alzheimer\u00e2\u20ac\u2122s Disease Cooperative Study.","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"55833","DOI":"10.1074\/jbc.M409954200","article-title":"Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis.","volume":"279","author":"Schneider","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3940(02)00164-7","article-title":"Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer\u00e2\u20ac\u2122s disease compared to healthy controls.","volume":"324","author":"Schonknecht","year":"2002","journal-title":"Neurosci. Lett."},{"key":"B141","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WAD.0b013e3181d61fea","article-title":"Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.","volume":"24","author":"Serrano-Pozo","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial \u00e2\u20ac\u201c Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","article-title":"Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch. Neurol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice.","volume":"13","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"key":"B147","doi-asserted-by":"publisher","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","article-title":"Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.","volume":"285","author":"Shinohara","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B149","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ana.10292","article-title":"Treatment with simvastatin in normocholesterolemic patients with Alzheimer\u00e2\u20ac\u2122s disease: a 26-week randomized, placebo-controlled, double-blind trial.","volume":"52","author":"Simons","year":"2002","journal-title":"Ann. Neurol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000069989","article-title":"Treatment with simvastatin in patients with Alzheimer\u00e2\u20ac\u2122s disease lowers both alpha- and beta-cleaved amyloid precursor protein.","volume":"16","author":"Sjogren","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia.","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"B152","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/JGP.0b013e31818cd3a4","article-title":"Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.","volume":"16","author":"Small","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking A beta and tau in late-onset Alzheimer\u00e2\u20ac\u2122s disease: a dual pathway hypothesis.","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"B154","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1749-6632.1997.tb48466.x","article-title":"Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer\u00e2\u20ac\u2122s disease?","volume":"826","author":"Sparks","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2174\/156720508785132316","article-title":"Reduced risk of incident AD with elective statin use in a clinical trial cohort.","volume":"5","author":"Sparks","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/01.HYP.0000259737.43916.42","article-title":"Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.","volume":"49","author":"Strazzullo","year":"2007","journal-title":"Hypertension"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1083\/jcb.200404106","article-title":"BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation.","volume":"167","author":"Suzuki","year":"2004","journal-title":"J. Cell Biol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","article-title":"Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).","volume":"62","author":"Svennerholm","year":"1994","journal-title":"J. Neurochem."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1039\/c0mb00302f","article-title":"Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.","volume":"7","author":"Takeda","year":"2011","journal-title":"Mol. Biosyst."},{"key":"B160","doi-asserted-by":"publisher","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","article-title":"Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.","volume":"285","author":"Tamboli","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.","volume":"163","author":"Tan","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2011.06.031","article-title":"HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7.","volume":"217","author":"Tanaka","year":"2011a","journal-title":"Atherosclerosis"},{"key":"B163","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5551\/jat.6726","article-title":"Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system.","volume":"18","author":"Tanaka","year":"2011b","journal-title":"J. Atheroscler. Thromb."},{"key":"B164","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0197-4580(03)00005-8","article-title":"Combination of serum markers related to several mechanisms in Alzheimer\u00e2\u20ac\u2122s disease.","volume":"24","author":"Teunissen","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B165","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","article-title":"Cerebral amyloid angiopathy and its relationship to Alzheimer\u00e2\u20ac\u2122s disease.","volume":"115","author":"Thal","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B167","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1523\/JNEUROSCI.0169-12.2012","article-title":"Age-dependent rescue by simvastatin of Alzheimer\u00e2\u20ac\u2122s disease cerebrovascular and memory deficits.","volume":"32","author":"Tong","year":"2012","journal-title":"J. Neurosci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nbd.2009.06.003","article-title":"Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.","volume":"35","author":"Tong","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"618.e1","DOI":"10.1016\/j.neurobiolaging.2010.11.011","article-title":"The effects of APOE on brain activity do not simply reflect the risk of Alzheimer\u00e2\u20ac\u2122s disease.","volume":"33","author":"Trachtenberg","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BST0340399","article-title":"Lipid dynamics in neurons.","volume":"3)","author":"Vance","year":"2006","journal-title":"Biochem. Soc. Trans. 34(Pt"},{"key":"B171","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/archneur.60.4.510","article-title":"Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.","volume":"60","author":"Vega","year":"2003","journal-title":"Arch. Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u00e2\u20ac\u2122s disease and other neurological disorders.","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"Statin-associated memory loss: analysis of 60 case reports and review of the literature.","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy"},{"key":"B174","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","article-title":"Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.","volume":"9","author":"Wahrle","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.ijo.0802287","article-title":"Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.","volume":"27","author":"Watts","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"7","key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u00e2\u20ac\u2122s Disease Neuroimaging Initiative: a review of papers published since its inception.","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B177","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-009-0498-z","article-title":"Microvasculature changes and cerebral amyloid angiopathy in Alzheimer\u00e2\u20ac\u2122s disease and their potential impact on therapy.","volume":"118","author":"Weller","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(97)04430-9","article-title":"Total cholesterol and risk of mortality in the oldest old.","volume":"350","author":"Weverling-Rijnsburger","year":"1997","journal-title":"Lancet"},{"key":"B179","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJM200008033430502","article-title":"Pravastatin therapy and the risk of stroke.","volume":"343","author":"White","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neurobiolaging.2009.02.003","article-title":"The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.","volume":"32","author":"Wisdom","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/j.1471-4159.2008.05283.x","article-title":"Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts.","volume":"105","author":"Won","year":"2008","journal-title":"J. Neurochem."},{"key":"B183","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/pds.3381","article-title":"Statins in the prevention of dementia and Alzheimer\u00e2\u20ac\u2122s disease: a meta-analysis of observational studies and an assessment of confounding.","volume":"22","author":"Wong","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B184","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"B185","doi-asserted-by":"publisher","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","article-title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.","volume":"287","author":"Xiao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B186","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/brain\/aws271","article-title":"Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.","volume":"12)","author":"Yarchoan","year":"2012","journal-title":"Brain 135(Pt"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer\u00e2\u20ac\u2122s disease in a defined elderly Japanese population: the Hisayama Study.","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"key":"B188","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","article-title":"The role of clusterin in Alzheimer\u00e2\u20ac\u2122s disease: pathways, pathogenesis, and therapy.","volume":"45","author":"Yu","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and Alzheimer\u00e2\u20ac\u2122s disease.","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.","volume":"62","author":"Zandi","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"B191","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins: basic research and clinical perspectives.","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ. J."},{"key":"B192","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1096\/fj.07-8175com","article-title":"Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.","volume":"22","author":"Zhou","year":"2008","journal-title":"FASEB J."},{"key":"B193","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","article-title":"Alzheimer disease, the two-hit hypothesis: an update.","volume":"1772","author":"Zhu","year":"2007","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T20:43:57Z","timestamp":1565383437000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2014.00071\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":193,"URL":"https:\/\/doi.org\/10.3389\/fnagi.2014.00071","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}